Understanding the Patient Journey of African, Caribbean, and Black Newcomer Albertans
Summary
Dr. Doreen Rabi and her research team would like to learn from African, Caribbean, and Black newcomer Albertans about their experiences of seeking health care in Alberta.
If you volunteer to participate in this study, we will ask you to speak with two members of the research team for about one hour (60 minutes) about your health care experiences since arriving in Alberta. We will be be asking you questions about your background, what your health care needs have been, and how you have addressed your health issues along the way.
Interviews or focus groups will be run online or in person.
Eligibility
Eligible ages: 18 to 90
Accepts healthy participants: Yes
Inclusion criteria:
1. Identify as African, Caribbean, Black newcomers to Alberta
2. 18 years+
Exclusion criteria:
1. Individuals who do not identify as African, Caribbean, or Black
2. Individuals who are not newcomers to Alberta (Canada)
3. Individuals under the age of majority (18)
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Please contact Marie-Claire Uwamahoro (marieclaire.uwamahor@ucalgary.ca) or leave a message (403-210-7389)
Principal investigator:
Doreen Rabi
Clinical trial:
No
REB-ID:
REB22-0198